CLINICAL_TRIALS
research
· 2017-04-26
Clinical Trial Update: Benefits of Nigella Sativa in Children With Beta Thalassemia Major [EARLY_Phase 1]
Summary
An early-phase 1 clinical trial investigating Nigella Sativa for children with beta-thalassemia major, with the trial status not specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Nigella Sativa With Beta Thalassemia Major | EARLY_Phase 1 | Status: UNKNOWN